Supraventricular tachycardia AHA recommendations for Management of Atrial Flutter: Difference between revisions
Aysha Aslam (talk | contribs) (Created page with "__NOTOC__ {{Supraventricular tachycardia}} {{CMG}} {{AE}}{{AA}} ==Overview== == Management of Atrial Flutter== ==References== {{Reflist|2}}") |
Aysha Aslam (talk | contribs) |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
== Management of Atrial Flutter== | == Management of Atrial Flutter== | ||
===Acute treatment of Atrial Flutter=== | |||
{|class="wikitable" style="width:80%" | |||
|- | |||
|colspan="1" style="text-align:center; background:LightGreen"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]] | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.'''Oral dofetilide or intravenous ibutilide is useful for acute pharmacological cardioversion in patients with atrial flutter <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: A ]])'' <nowiki>"</nowiki> | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''2.'''Intravenous or oral beta blockers, diltiazem, or verapamil are useful for acute rate control in patients with atrial flutter who are hemodynamically stable<nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B-R]])'' <nowiki>"</nowiki> | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''3.Elective synchronized cardioversion is indicated in stable patients with well-tolerated atrial flutter when a rhythm-control strategy is pursued <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence:B-NR ]])'' <nowiki>"</nowiki> | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''4.Synchronized cardioversion is recommended for acute treatment of patients with atrial flutter who are hemodynamically unstable and do not respond to pharmacological therapies <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B-NR ]])'' <nowiki>"</nowiki> | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''5.Rapid atrial pacing is useful for acute conversion of atrial flutter in patients who have pacing wires in place as part of a permanent pacemaker or implantable cardioverter-defibrillator or for temporary atrialpacing after cardiac surgery<nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C-LD ]])'' <nowiki>"</nowiki> | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''6.Acute antithrombotic therapy is recommended in patients with atrial flutter to align with recommended antithrombotic therapy for patients with AF <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence:B-NR ]])'' <nowiki>"</nowiki> | |||
|} | |||
{|class="wikitable" style="width:80%" | |||
|- | |||
|colspan="1" style="text-align:center; background:LemonChiffon"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]] | |||
|- | |||
| bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.'''Intravenous amiodarone can be useful for acute control of the ventricular rate (in the absence of pre-excitation in patients with atrial flutter and systolic heart failure, when beta blockers are contraindicated or ineffective<nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence:B-R ]])'' <nowiki>"</nowiki> | |||
|} | |||
{|class="wikitable" style="width:80%" | |||
|- | |||
| colspan="1" style="text-align:center; background:LemonChiffon"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIb]] | |||
|- | |||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.'''<nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence:]])'' <nowiki>"</nowiki> | |||
|- | |||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''2.'''<nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence:]])'' <nowiki>"</nowiki> | |||
|} | |||
===Management of ongoing Atrial Flutter=== | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 17:44, 26 October 2016
Supraventricular tachycardia Microchapters |
Differentiating Among the Different Types of Supraventricular Tachycardia |
---|
Differentiating Supraventricular Tachycardia from Ventricular Tachycardia |
Diagnosis |
Treatment |
2015 ACC/AHA Guideline Recommendations |
Case Studies |
Supraventricular tachycardia AHA recommendations for Management of Atrial Flutter On the Web |
American Roentgen Ray Society Images of Supraventricular tachycardia AHA recommendations for Management of Atrial Flutter |
FDA on Supraventricular tachycardia AHA recommendations for Management of Atrial Flutter |
CDC on Supraventricular tachycardia AHA recommendations for Management of Atrial Flutter |
Supraventricular tachycardia AHA recommendations for Management of Atrial Flutter in the news |
Blogs on Supraventricular tachycardia AHA recommendations for Management of Atrial Flutter |
Directions to Hospitals Treating Supraventricular tachycardia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]
Overview
Management of Atrial Flutter
Acute treatment of Atrial Flutter
Class I |
"1.Oral dofetilide or intravenous ibutilide is useful for acute pharmacological cardioversion in patients with atrial flutter "(Level of Evidence: A ) " |
"2.Intravenous or oral beta blockers, diltiazem, or verapamil are useful for acute rate control in patients with atrial flutter who are hemodynamically stable"(Level of Evidence: B-R) " |
"3.Elective synchronized cardioversion is indicated in stable patients with well-tolerated atrial flutter when a rhythm-control strategy is pursued "(Level of Evidence:B-NR ) " |
"4.Synchronized cardioversion is recommended for acute treatment of patients with atrial flutter who are hemodynamically unstable and do not respond to pharmacological therapies "(Level of Evidence: B-NR ) " |
"5.Rapid atrial pacing is useful for acute conversion of atrial flutter in patients who have pacing wires in place as part of a permanent pacemaker or implantable cardioverter-defibrillator or for temporary atrialpacing after cardiac surgery"(Level of Evidence: C-LD ) " |
"6.Acute antithrombotic therapy is recommended in patients with atrial flutter to align with recommended antithrombotic therapy for patients with AF "(Level of Evidence:B-NR ) " |
Class IIa |
"1.Intravenous amiodarone can be useful for acute control of the ventricular rate (in the absence of pre-excitation in patients with atrial flutter and systolic heart failure, when beta blockers are contraindicated or ineffective"(Level of Evidence:B-R ) " |
Class IIb |
"1."(Level of Evidence:) " |
"2."(Level of Evidence:) " |